LY2334737
LY2334737 is an orally administered prodrug of the antimetabolite gemcitabine. It is designed to improve bioavailability and is used in oncology research to study its antitumor effects in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
892128-60-8
Product Name Alternative
Anticancer, antiviral, Analog, Inhibitor, HEVs, HEV, Gemcitabine, HRV, HRVs, Enterovirus, EV-A71, inhibit, LY2334737, LY-2334737, LY 2334737, NucleosideAntimetabolite, Nucleoside Antimetabolite, Nucleoside Antimetabolite/Analog, orally, Rhinovirus, Virus Protease, VirusProtease
Field of Research
Cell Biology, Infectious Disease & Virology, Molecular Biology
Purity
98.82% (May vary between batches)
Solubility
DMSO:45 mg/mL (115.57 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.14 mM)
Smiles
CCCC (CCC) C (=O) Nc1ccn ([C@@H]2O[C@H] (CO) [C@@H] (O) C2 (F) F) c (=O) n1
Molecular Formula
C17H25F2N3O5
Molecular Weight
389.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
